Clinical Trial Update: Evaluating the Safety of Myfortic (Mycophenolate Sodium) in Patients With Lupus Nephritis

View source ↗

Summary

A completed clinical trial evaluating the safety of Myfortic (mycophenolate sodium) in patients with lupus nephritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lupus Nephritis

Drugs mentioned

• MYFORTIC (MYCOPHENOLIC ACID)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Lupus Nephritis | Status: COMPLETED